Scarica l'app Stockscreener
0.654
8.54%
-0.0611
Dopo l'orario di chiusura:
.67
0.016
+2.45%
Co Diagnostics Inc Borsa (CODX) Ultime notizie
Co-Diagnostics taps J.J. Astor for $2.1M convertible loan to fund operations - Dealroom
Dwight Evans Stock Trades and Disclosures - TechGraph
Daniel S Sullivan Stock Trades and Disclosures - TechGraph
Co-Diagnostics (Nasdaq:CODX)Stock Analysis - simplywall.st
Co-Diagnostics, Inc. (CODX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Up to 1-for-50 reverse split on table at Co-Diagnostics (NASDAQ: CODX) - Stock Titan
Ebola outbreak is focus of a New York health roundtable. Co-Dx will join. - Stock Titan
Co-Diagnostics to Hold Press Conference - Yahoo Finance
Co-Diagnostics (CODX) finance EVP details RSU grants vesting through 2028 - Stock Titan
Q1 2026 Co-Diagnostics Inc Earnings Call Transcript - GuruFocus
CeriBell, Inc.Common Stock (CBLL) Stock Price, News, Quote & History - FinancialContent
Co-Diagnostics Completes New Vector Smart® Laboratory Installations Amid Rising Dengue Activity in Florida - PR Newswire
United Natural Foods, ABM Industries and 3 Stocks to Watch Heading Into Tuesday - Benzinga
Weekly Recap: International Vector Smart kit deployment and CFO resignation - TradingView
Co-Diagnostics, Inc. Announces Executive Changes, Effective September 2, 2026 - marketscreener.com
CODX Looks 32.6% Undervalued on GF Value™ Amid Challenging Funda - GuruFocus
Co-Diagnostics Launches Integrated Cloud and Mobile Infrastructure in India - Morningstar
Co-Diagnostics Launches Integrated Cloud and Mobile Infrastructure in India - Yahoo Finance
Co-Diagnostics, Inc. SEC Filing (Sep 2, 2026) - Stock Titan
CODX Looks 31.4% Undervalued on GF Value™ - GuruFocus
A mosquito surveillance system reaches an overseas U.S. Air Force base - Stock Titan
Quest Diagnostics (NYSE: DGX) holder to sell 22,677 shares - Stock Titan
Co-Diagnostics Inc. (CODX) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Co-Diagnostics Inc (CODX) Stock News Today - TradingKey
CODX Forecast — Price Target — Prediction for 2027 - tradingview.com
ARMISTICE CAPITAL, LLC Buys Co-Diagnostics Inc (CODX) -- Shares Look 33% Undervalued on GF Value - GuruFocus
Co-Dx (CODX) Q2 2026 Earnings Call Transcript - The Globe and Mail
Co-diagnostics Company Profile & Introduction - Moomoo
Co-Dx (CODX) Q2 2026 Earnings Call Transcript - The Globe and Mail
Co-Diagnostics (CODX) Snapshot: Ends Up by 4.37% at $1.31 in the Current Update; Chart View - vinanet.vn
Co-Diagnostics (CODX) Financial Results: EPS Falls Short of Its Estimate for This Review; Price Reaction: Shares Move 5.97% Lower in the Available RecordEarnings Call Q&A - vinanet.vn
Co-Diagnostics seeks FDA clearance for new PCR Flu A/B & RSV test, prepping for U.S. launch. - Pluang
Co-Diagnostics joins Utah roundtable on AI and medical devices - Stock Titan
Co-Diagnostics Participates in Medical Devices and Innovations Roundtable Media Event - PR Newswire
Maxim Group Upgrades Co-Diagnostics to Buy From Hold, $4 Price Target - marketscreener.com
Company-diagnostics Stock Price Forecast. Should You Buy CODX? - StockInvest.us
Co-Diagnostics Inc (CODX) Stock News Today - TradingKey
Armistice Capital discloses 9.99% Co-Diagnostics (CODX) holding via Master Fund - Stock Titan
Co-diagnostics | SCHEDULE 13G: Others - Moomoo
Co-Diagnostics, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Co-diagnostics(CODX) Stock Options Chain | Quotes & News - Moomoo
Co-Diagnostics (CODX) Earnings Call Q2 2026: FDA-Antrag schreitet voran, während Barmittel sinken - TradingKey
Co-Diagnostics (CODX) Q2 2026 Earnings Call: FDA Filing Advances as Cash Falls - TradingKey
Co-Diagnostics Inc (CODX) (Q2 2026) Earnings Call Highlights: FD - GuruFocus
Co-Diagnostics Inc (CODX) (Q2 2026) Earnings Call Highlights: FD - GuruFocus
Is Co-Diagnostics Inc (CODX) Undervalued Despite Q2 Earnings Mis - GuruFocus
Co-Diagnostics Q2 Results: Net loss narrows to $6.3 million - scanx.trade
Co-Diagnostics Reports Q2 2026 Results: Full Earnings Call Transcript - Benzinga
Earnings call transcript: Co-Diagnostics narrows loss in Q2 2026 but revenue stays thin - Investing.com
Co-Diagnostics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
18.66%
1.92%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):